Sec. 936, R&D/orphan drug tax credit may be included in debt ceiling bill.
Executive Summary
SEC. 936, R&D, ORPHAN DRUG TAX CREDIT INCLUSION IN DEBT CEILING BILL is under consideration by congressional Republicans if the bill to raise the government's borrowing limit is permitted to have riders. The pharmaceutical industry tax credit proposals have been in limbo since President Clinton vetoed the budget package (HR 2491) on Dec. 6.